PLEKHG2 and leukemia: In 2013, Runne et al. first reported that PLEKHG2 contributed to Jurkat T cell migration by promoting the heterotrimeric G protein βγ12, suggesting that PLEKHG2 may be associated with poor prognosis in leukemia.